The application of NGS has identified common genetic alterations in squamous cell lung cancer, including TP53 (64.5%), PIK3CA (28.5%), CDKN2A (24.4%), SOX2 (17.7%), and CCND1 (15.8%) [25]. This evidence concerns the gene CDKN2A and squamous cell lung carcinoma.